HCA Healthcare officer plans $5.63M share sale

The notice also reports HCA had 216,501,500 shares outstanding.

Rhea-AI Filing Summary

HCA Healthcare, Inc. (HCA) is named as issuer in a Rule 144 notice listing an anticipated sale by Michael S Cuffe, identified as an officer, of 11,800 common shares with an aggregate market value of $5,628,600. Merrill Lynch is listed as broker, and October 29, 2026 is the approximate sale date.

Key Figures

Common shares listed for sale: 11,800 shares Aggregate market value: $5,628,600 Shares outstanding: 216,501,500 shares +3 more

6 metrics

Common shares listed for sale 11,800 shares Anticipated sale by Michael S Cuffe

Aggregate market value $5,628,600 Securities listed for sale

Shares outstanding 216,501,500 shares HCA Healthcare, Inc.

Shares from performance award vest 1,747 shares February 13, 2025

Shares from performance award vest 6,127 shares February 10, 2026

Shares from exercise of a stock appreciation right 3,926 shares October 29, 2026

Key Terms

Rule 144, aggregate market value, Performance Award Vest, Compensatory Payment

4 terms

Rule 144 regulatory

"144: Filer Information"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

aggregate market value financial

"Securities Information"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Performance Award Vest technical

"Performance Award Vest"

Compensatory Payment financial

"Compensatory Payment"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HCA shares does Michael S Cuffe plan to sell?

Michael S Cuffe's Rule 144 notice lists an anticipated sale of 11,800 HCA common shares, with an aggregate market value of $5,628,600. Merrill Lynch is listed as broker, and October 29, 2026 is the approximate sale date.

What are the listed sources of Michael S Cuffe's HCA shares?

The notice lists 1,747 shares from a performance award vest dated February 13, 2025, 6,127 shares from a performance award vest dated February 10, 2026, and 3,926 shares from an exercise of a stock appreciation right dated October 29, 2026. Each is shown as a compensatory payment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/29/2026 - 04:19 PM EDT Accepted by SEC EDGAR 10/29/2026 - 04:18 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001632835
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	HCA Healthcare, Inc
SEC File Number	001-11239
Address of Issuer	One Park Plaza Nashville TENNESSEE 37203
Phone	615-344-9551
Name of Person for Whose Account the Securities are To Be Sold	Michael S Cuffe
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 3455 Peachtree Road NE Suite 1000 Atlanta GA 30326	11800	5628600	216501500	10/29/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/13/2025	Performance Award Vest	HCA Healthcare, Inc			1747	02/13/2025	Compensatory Payment
Common	02/10/2026	Performance Award Vest	HCA Healthcare, Inc			6127	02/10/2026	Compensatory Payment
Common	10/29/2026	Exercise of a Stock Apprectiation Right	HCA Helathcare, Inc			3926	10/29/2026	Compensatory Payment

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	10/29/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Michael S Cuffe
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)